CoChat

Conditional Silencing of H-2Db Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen–Specific CD8 T Cell Responses during Theiler's Virus Infection

Tritz, Zachariah P, Orozco, Robin C, Malo, Courtney S, Ayasoufi, Katayoun, Fain, Cori E, Khadka, Roman H, Goddery, Emma N, Yokanovich, Lila T, Settell, Megan L, Hansen, Michael J, Jin, Fang, Pavelko, Kevin D, Pease, Larry R, Johnson, Aaron J · 2020 · The Journal of Immunology

Published version of a preprint

Cited by 18

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Theiler's murine encephalomyelitis virus (TMEV) infection of the CNS is cleared in C57BL/6 mice by a CD8 T cell response restricted by the MHC class I molecule H-2Db. The identity and function of the APC(s) involved in the priming of this T cell response is (are) poorly defined. To address this gap in knowledge, we developed an H-2Db LoxP-transgenic mouse system using otherwise MHC class I–deficient C57BL/6 mice, thereby conditionally ablating MHC class I–restricted Ag presentation in targeted APC subpopulations. We observed that CD11c+ APCs are critical for early priming of CD8 T cells against the immunodominant TMEV peptide VP2121-130. Loss of H-2Db on CD11c+ APCs mitigates the CD8 T cell response, preventing early viral clearance and immunopathology associated with CD8 T cell activity in the CNS. In contrast, animals with H-2Db–deficient LysM+ APCs retained early priming of Db:VP2121-130 epitope–specific CD8 T cells, although a modest reduction in immune cell entry into the CNS was observed. This work establishes a model enabling the critical dissection of H-2Db–restricted Ag presentation to CD8 T cells, revealing cell-specific and temporal features involved in the generation of CD8 T cell responses. Employing this novel system, we establish CD11c+ cells as pivotal to the establishment of acute antiviral CD8 T cell responses against the TMEV immunodominant epitope VP2121-130, with functional implications both for T cell–mediated viral control and immunopathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.2000340

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 69

  1. Mockus, 2019, To go or stay: the development, benefit, and detriment of tissue-resident memory CD8 T cells during central nervous system viral infections, 842
  2. Aguilar-Valenzuela, 2018, Dynamics of tissue-specific CD8+ T cell responses during west nile virus infection, J. Virol., 92, 10.1128/JVI.00014-18 · DOI
  3. Wang, 2003, CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis, J. Virol., 77, 13323, 10.1128/JVI.77.24.13323-13334.2003 · DOI · Paper page
  4. Guermonprez, 2002, Antigen presentation and T cell stimulation by dendritic cells, Annu. Rev. Immunol., 20, 621, 10.1146/annurev.immunol.20.100301.064828 · DOI · Paper page
  5. Bulloch, 2008, CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain, J. Comp. Neurol., 508, 687, 10.1002/cne.21668 · DOI · Paper page
  6. McMenamin, 1999, Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations, J. Comp. Neurol., 405, 553, 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6 · DOI · Paper page
  7. Prodinger, 2011, CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system, Acta Neuropathol., 121, 445, 10.1007/s00401-010-0774-y · DOI
  8. Clarkson, 2014, Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE, J. Neuroimmunol., 277, 39, 10.1016/j.jneuroim.2014.09.016 · DOI
  9. Clarkson, 2015, CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression, J. Immunol., 194, 531, 10.4049/jimmunol.1401320 · DOI
  10. De Laere, 2018, To the brain and back: migratory paths of dendritic cells in multiple sclerosis, J. Neuropathol. Exp. Neurol., 77, 178, 10.1093/jnen/nlx114 · DOI
  11. Bernhard, 2015, CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells, Proc. Natl. Acad. Sci. USA, 112, 5461, 10.1073/pnas.1423356112 · DOI · Paper page
  12. Kivisäkk, 2009, Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis, Ann. Neurol., 65, 457, 10.1002/ana.21379 · DOI · Paper page
  13. Pope, 1998, Characterization of and functional antigen presentation by central nervous system mononuclear cells from mice infected with Theiler’s murine encephalomyelitis virus, J. Virol., 72, 7762, 10.1128/JVI.72.10.7762-7771.1998 · DOI
  14. van Zwam, 2011, Myelin ingestion alters macrophage antigen-presenting function in vitro and in vivo, J. Leukoc. Biol., 90, 123, 10.1189/jlb.1209813 · DOI
  15. Libbey, 2014, Axonal pathology and demyelination in viral models of multiple sclerosis, Discov. Med., 18, 79
  16. DePaula-Silva, 2017, Theiler’s murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: models for multiple sclerosis and epilepsy, J. Neuroimmunol., 308, 30, 10.1016/j.jneuroim.2017.02.012 · DOI · Paper page
  17. Drescher, 2008, Being a mouse in a man’s world: what TMEV has taught us about human disease, Front. Biosci., 13, 3775, 10.2741/2966 · DOI
  18. Tsunoda, 2010, Neuropathogenesis of Theiler’s murine encephalomyelitis virus infection, an animal model for multiple sclerosis, J. Neuroimmune Pharmacol., 5, 355, 10.1007/s11481-009-9179-x · DOI · Paper page
  19. Azoulay, 1994, FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler’s virus, J. Virol., 68, 4049, 10.1128/jvi.68.6.4049-4052.1994 · DOI
  20. Rodriguez, 1985, Demyelination induced by Theiler’s virus: influence of the H-2 haplotype, J. Immunol., 135, 2145, 10.4049/jimmunol.135.3.2145 · DOI · Paper page
  21. Rodriguez, 1995, H-2 Dd transgene suppresses Theiler’s virus-induced demyelination in susceptible strains of mice, J. Neurovirol., 1, 111, 10.3109/13550289509111015 · DOI
  22. Bell, 2014, An elite controller of picornavirus infection targets an epitope that is resistant to immune escape, PLoS One, 9, 10.1371/journal.pone.0094332 · DOI
  23. Borson, 1997, Brain-infiltrating cytolytic T lymphocytes specific for Theiler’s virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue, J. Virol., 71, 5244, 10.1128/jvi.71.7.5244-5250.1997 · DOI · Paper page
  24. Dethlefs, 1997, Theiler’s virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice, J. Virol., 71, 5361, 10.1128/jvi.71.7.5361-5365.1997 · DOI
  25. Johnson, 1999, Prevalent class I-restricted T-cell response to the Theiler’s virus epitope Db:VP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28, J. Virol., 73, 3702, 10.1128/JVI.73.5.3702-3708.1999 · DOI · Paper page
  26. Johnson, 2001, Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler’s virus infection, FASEB J., 15, 2760, 10.1096/fj.01-0373fje · DOI
  27. Willenbring, 2016, Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption, J. Neuroinflammation, 13, 222, 10.1186/s12974-016-0673-9 · DOI · Paper page
  28. Mendez-Fernandez, 2003, Clearance of Theiler’s virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide, Eur. J. Immunol., 33, 2501, 10.1002/eji.200324007 · DOI · Paper page
  29. Johnson, 2005, Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome, J. Immunol., 174, 6854, 10.4049/jimmunol.174.11.6854 · DOI · Paper page
  30. Johnson, 2012, CD8 T cell-initiated blood-brain barrier disruption is independent of neutrophil support, J. Immunol., 189, 1937, 10.4049/jimmunol.1200658 · DOI
  31. Johnson, 2012, A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption, J. Neuroinflammation, 9, 60, 10.1186/1742-2094-9-60 · DOI
  32. Johnson, 2014, Theiler’s murine encephalomyelitis virus as an experimental model system to study the mechanism of blood-brain barrier disruption, J. Neurovirol., 20, 107, 10.1007/s13365-013-0187-5 · DOI
  33. Johnson, 2014, Perforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption, PLoS One, 9, 10.1371/journal.pone.0111401 · DOI · Paper page
  34. Malo, 2018, Non-equivalent antigen presenting capabilities of dendritic cells and macrophages in generating brain-infiltrating CD8 + T cell responses, Nat. Commun., 9, 633, 10.1038/s41467-018-03037-x · DOI
  35. Cumba Garcia, 2016, Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique, J. Immunol. Methods, 439, 23, 10.1016/j.jim.2016.09.002 · DOI
  36. Rodriguez, 1986, Partial suppression of Theiler’s virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens), Neurology, 36, 964, 10.1212/WNL.36.7.964 · DOI · Paper page
  37. Abram, 2014, Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice, J. Immunol. Methods, 408, 89, 10.1016/j.jim.2014.05.009 · DOI · Paper page
  38. Noubade, 2019, Beyond cDC1: emerging roles of DC crosstalk in cancer immunity, Front. Immunol., 10, 1014, 10.3389/fimmu.2019.01014 · DOI
  39. McCaughtry, 2008, Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla, J. Exp. Med., 205, 2575, 10.1084/jem.20080866 · DOI · Paper page
  40. Klein, 2014, Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see), Nat. Rev. Immunol., 14, 377, 10.1038/nri3667 · DOI · Paper page
  41. Oh, 2015, The role of dendritic cells in central tolerance, Immune Netw., 15, 111, 10.4110/in.2015.15.3.111 · DOI
  42. Tsunoda, 2008, Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection, Future Virol., 3, 579, 10.2217/17460794.3.6.579 · DOI
  43. Lipton, 1975, Theiler’s virus infection in mice: an unusual biphasic disease process leading to demyelination, Infect. Immun., 11, 1147, 10.1128/iai.11.5.1147-1155.1975 · DOI · Paper page
  44. Palma, 2001, Enhanced susceptibility to Theiler’s virus-induced demyelinating disease in perforin-deficient mice, J. Neuroimmunol., 116, 125, 10.1016/S0165-5728(01)00293-4 · DOI
  45. Fiette, 1993, Theiler’s virus infection of beta 2-microglobulin-deficient mice, J. Virol., 67, 589, 10.1128/jvi.67.1.589-592.1993 · DOI
  46. Rodriguez, 1993, Abrogation of resistance to Theiler’s virus-induced demyelination in H-2b mice deficient in beta 2-microglobulin, J. Immunol., 151, 266, 10.4049/jimmunol.151.1.266 · DOI
  47. Rodriguez, 1991, Role of T cells in resistance to Theiler’s virus infection, Microb. Pathog., 11, 269, 10.1016/0882-4010(91)90031-5 · DOI
  48. Suidan, 2008, Induction of blood brain barrier tight junction protein alterations by CD8 T cells, PLoS One, 3, 10.1371/journal.pone.0003037 · DOI · Paper page
  49. Ling, 2008, In situ activation of antigen-specific CD8+ T cells in the presence of antigen in organotypic brain slices, J. Immunol., 180, 8393, 10.4049/jimmunol.180.12.8393 · DOI
  50. Mendez-Fernandez, 2005, Anatomical and cellular requirements for the activation and migration of virus-specific CD8+ T cells to the brain during Theiler’s virus infection, J. Virol., 79, 3063, 10.1128/JVI.79.5.3063-3070.2005 · DOI
  51. Probst, 2005, Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells, Clin. Exp. Immunol., 141, 398, 10.1111/j.1365-2249.2005.02868.x · DOI · Paper page
  52. Steel, 2009, Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system, Virology, 387, 117, 10.1016/j.virol.2009.01.032 · DOI · Paper page
  53. Altintas, 1993, Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler’s virus, J. Immunol., 151, 2803, 10.4049/jimmunol.151.5.2803 · doi:10.4049/jimmunol.151.5.2803
  54. Lin, 1997, Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection, Eur. J. Immunol., 27, 963, 10.1002/eji.1830270424 · DOI
  55. Njenga, 1997, Interferon alpha/beta mediates early virus-induced expression of H-2D and H-2K in the central nervous system, Lab. Invest., 77, 71
  56. Pavelko, 2012, Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity, PLoS Pathog., 8, 10.1371/journal.ppat.1002541 · DOI
  57. MacNamara, 2008, Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain dependent, J. Virol., 82, 6150, 10.1128/JVI.00106-08 · DOI
  58. Herz, 2011, In vivo imaging of lymphocytes in the CNS reveals different behaviour of naïve T cells in health and autoimmunity, J. Neuroinflammation, 8, 131, 10.1186/1742-2094-8-131 · DOI
  59. Hughes, 2016, Antigen-presenting cells and antigen presentation in tertiary lymphoid organs, Front. Immunol., 7, 481, 10.3389/fimmu.2016.00481 · DOI
  60. Mitsdoerffer, 2016, Tertiary lymphoid organs in central nervous system autoimmunity, Front. Immunol., 7, 451, 10.3389/fimmu.2016.00451 · DOI · Paper page
  61. Cose, 2006, Evidence that a significant number of naive T cells enter non-lymphoid organs as part of a normal migratory pathway, Eur. J. Immunol., 36, 1423, 10.1002/eji.200535539 · DOI · Paper page
  62. Allan, 2006, Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming, Immunity, 25, 153, 10.1016/j.immuni.2006.04.017 · DOI · Paper page
  63. Brabb, 2000, In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity, J. Exp. Med., 192, 871, 10.1084/jem.192.6.871 · DOI · Paper page
  64. Reynoso, 2019, Lymph node conduits transport virions for rapid T cell activation, Nat. Immunol., 20, 602, 10.1038/s41590-019-0342-0 · DOI · Paper page
  65. Milo, 2013, Dynamic imaging reveals promiscuous crosspresentation of blood-borne antigens to naive CD8+ T cells in the bone marrow, Blood, 122, 193, 10.1182/blood-2012-01-401265 · DOI
  66. Pozzi, 2005, Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells, J. Immunol., 175, 2071, 10.4049/jimmunol.175.4.2071 · DOI · Paper page
  67. Jarry, 2013, Efficiently stimulated adult microglia cross-prime naive CD8+ T cells injected in the brain, Eur. J. Immunol., 43, 1173, 10.1002/eji.201243040 · DOI
  68. Coder, 2017, Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging, Oncotarget, 8, 7116, 10.18632/oncotarget.12572 · DOI · Paper page
  69. McGavern, 2002, T cells in the central nervous system: the delicate balance between viral clearance and disease, J. Infect. Dis., 186, S145, 10.1086/344264 · DOI · Paper page

Cited by

See all 18

Metadata

Authors
Tritz, Z. P., Orozco, R. C., Malo, C. S., Ayasoufi, K., Fain, C. E., Khadka, R. H., Goddery, E. N., Yokanovich, L. T., Settell, M. L., Hansen, M. J., Jin, F., Pavelko, K. D., Pease, L. R., & Johnson, A. J.
Affiliations
  • Mayo Clinic Graduate School of Biomedical Sciences , Rochester, MN 55905
  • Mayo Clinic Department of Immunology , Rochester, MN 55905
Venue
The Journal of Immunology
Published
2020-09-01
Volume
205
Issue
5
Pages
1228-1238
ISSN
  • 0022-1767
  • 1550-6606
Cited by
18
References
9
Language
en
Funders
  • National Institute of Neurological Disorders and Stroke (NS103212)
  • National Institutes of Health (T32 AI07425-24)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.